Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?

@article{Guilln2002IsIA,
  title={Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?},
  author={Juan C Quero Guill{\'e}n and Michael Groeneweg and Manuel Jim{\'e}nez S{\'a}enz and Solko W. Schalm and Juan Manuel Herrer{\'i}as Guti{\'e}rrez},
  journal={Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva},
  year={2002},
  volume={94 9},
  pages={544-57}
}
Minimal hepatic encephalopathy (MHE) refers to subtle neurocognitive and neurophysiological defects in patients with liver cirrhosis without clinical signs of hepatic encephalopathy. Using appropriate diagnostic methods the prevalence of MHE is approximately 25-30%. MHE has clinical significance as it results in a diminished daily functioning, precedes overt hepatic encephalopathy and is associated with a poor prognosis. Treatment with non-absorbable disaccharides can reverse the neurocognitive… CONTINUE READING